ARMP — Armata Pharmaceuticals Share News
0.000.00%
- $143.89m
- $403.45m
- $4.90m
Armata jumps on investment to advance lead drug in development
Brief: Cystic Fibrosis Foundation Makes Equity Investment In Armata Pharmaceuticals
Brief: Armata Pharmaceuticals Announces Second Quarter Results And Provides General Corporate Update
Brief: Armata Pharmaceuticals Announces Chief Executive Officer Transition
Brief: Armata Pharmaceuticals Announces First Quarter Results And Provides General Corporate Update
Brief: Innoviva Inc - Jules Haimovitz Appointed To Board Of Armata Pharmaceuticals
Brief: Armata Pharmaceuticals Posts Q4 Revenue $500,000
AMEX RESUMED ARMATA PHRMCUTCL
AMEX HALT ADDITIONAL INFORMATION LAST 5.210000
AMEX RESUMED ARMATA PHRMCUTCL
AMEX HALT ADDITIONAL INFORMATION LAST 7.000000
AMEX RESUMED ARMATA PHRMCUTCL
AMEX HALT ADDITIONAL INFORMATION LAST 8.570000
AMEX RESUMED ARMATA PHRMCUTCL
AMEX HALT ADDITIONAL INFORMATION LAST 8.250000
AMEX RESUMED ARMATA PHRMCUTCL
AMEX HALT ADDITIONAL INFORMATION LAST 6.330000
AMEX RESUMED ARMATA PHRMCUTCL
AMEX HALT ADDITIONAL INFORMATION LAST 4.950000